Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06829329 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 29, 2026 (before its estimated August 2, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 4 to 6v5
  2. Primary completion date: Oct 21, 2025 to Aug 2, 2026
    • Study completion date: Nov 2025 to Dec 2026
    • Secondary endpoints: details revised at 1 of 15 entries
    v4
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 124 to confirmed 105
    • Site details revised at 4 of 4 sites
    v3
  4. Enrollment target: 60 to 124v2 Show 6 more changesShow less
    • Primary endpoints: 2 to 1
    • Start date: Dec 5, 2024 to Dec 13, 2024
    • Interventions: AHB-137 (Drug), Placebo (Drug) to AHB-137 (Drug), NAs (Drug), Placebo (Drug)
    • Eligibility criteria shortened, about 152 words
    • Secondary endpoints revised (15)
    • Study title shortened, about 1 word
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is to evaluate the efficacy and safety of AHB-137 in CHB participants. The total duration of the study, including screening phase, treatment phase and follow-up phase.
Trial Details
NCT Number NCT06829329
Lead Sponsor Ausper Biopharma Co., Ltd.
Conditions
(from sponsor)		 Chronic Hepatitis B
Related terms Hepatitis B, Chronic
Enrollment 105 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov